No, I wouldn't consider that as two contributing factors to MDM. Remember that MDM is about decision-making. What is the provider documenting in their assessment and plan, i.e. what problems are they considering, what risk factors are involved, and what risks are posed to the patient by the treatment options they are proposing for management of those problems? 'Screening' is not one of these - again, screening is a preventive service and isn't part of a problem-oriented E&M service because it's not directed at any symptom or disease. There's no risk to a patient in being 'checked' if there are no symptoms or problems being considered, and no 'decision' involved in conducting a screening - remember that screening is something done for a patient with no signs, symptoms or history of a particular disease.
If the provider does document benign lesions or other abnormal findings during a screening, those could be counted, because there is a decision involved there - i.e. whether to biopsy or to monitor or do nothing - and there's a risk involved in that decision. And the history of a skin cancer does involve a risk too. But a screening does not. Just my thoughts on it though - others may take it differently. These are grey areas and the guidelines can only get you so far.